---
title: "Kazia Therapeutics Expands Oncology Platform with First-in-Class SETDB1 Inhibitor Drug Development Platform | KZIA Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282591392.md"
description: "Kazia Therapeutics Expands Oncology Platform with First-in-Class SETDB1 Inhibitor Drug Development Platform | KZIA Stock News"
datetime: "2026-04-13T13:10:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282591392.md)
  - [en](https://longbridge.com/en/news/282591392.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282591392.md)
---

# Kazia Therapeutics Expands Oncology Platform with First-in-Class SETDB1 Inhibitor Drug Development Platform | KZIA Stock News

Kazia Therapeutics Expands Oncology Platform with First-in-Class SETDB1 Inhibitor Drug Development Platform | KZIA Stock News

### Related Stocks

- [KZIA.US](https://longbridge.com/en/quote/KZIA.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer | KZIA Stock News](https://longbridge.com/en/news/287627288.md)
- [10:27 ET
			
			
				First-of-its-kind medical grade cannabis pharmacy launches in Colorado](https://longbridge.com/en/news/273106423.md)
- [Analyst Raises Kazia’s Price Target to $30 and Reiterates Buy on Strengthened Confidence in PI3K/AKT/mTOR Strategy](https://longbridge.com/en/news/288773686.md)
- [Health Care Up on Rotation Into Laggards — Health Care Roundup](https://longbridge.com/en/news/288908897.md)